Evaluation of [18F]MPPF as a Brain Tracer of Serotonin Receptor 5HT1a
Status:
Completed
Trial end date:
2014-05-01
Target enrollment:
Participant gender:
Summary
The underlying goal of this study is to assess [18F]MPPF PET imaging as a tool to evaluate
the activity of the serotonin 5HT1a receptor in the brain of Parkinson Disease (PD) research
participants.